ResearcherSichuan UniversityNo recent work listed

Rongping Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0349-2982; OpenAlex author ID A5055924995. Sources: OpenAlex.

Their work

Papers: 3 (first author 1, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 5

Papers, trials and grants by year

2022: 2 papers · 2023: 1 paper

Papers 3

High-Fat Mouse Model to Explore the Relationship between Abnormal Lipid Metabolism and Enolase in Pancreatic Cancer. Last author DOI 10.1155/2023/4965223 ↗
Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming. First author DOI 10.1016/j.actbio.2022.03.050 ↗
Cytotoxic terpenoids from Tripterygium hypoglaucum against human pancreatic cancer cells SW1990 by increasing the expression of Bax protein. Last author DOI 10.1016/j.jep.2022.115010 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lin Qin · 1 shared paper, 2023 · strength 0.24
- Paper High-Fat Mouse Model to Explore the Relationship between Abnormal Lipid Metabolism and Enolase in Pancreatic Cancer. DOI 10.1155/2023/4965223 ↗
Xing‐Long Chen · 1 shared paper, 2022 · strength 0.20
- Paper Cytotoxic terpenoids from Tripterygium hypoglaucum against human pancreatic cancer cells SW1990 by increasing the expre… DOI 10.1016/j.jep.2022.115010 ↗
Zhirong Zhang · 1 shared paper, 2022 · strength 0.17
- Paper Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradig… DOI 10.1016/j.actbio.2022.03.050 ↗
Qin He · 1 shared paper, 2022 · strength 0.17
- Paper Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradig… DOI 10.1016/j.actbio.2022.03.050 ↗
Ting Zhao · 1 shared paper, 2022 · strength 0.17
- Paper Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradig… DOI 10.1016/j.actbio.2022.03.050 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.